Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Long-Term Investments (2023 - 2024)

Cogent Biosciences' Long-Term Investments history spans 2 years, with the latest figure at $10.0 million for Q3 2024.

  • Quarterly Long-Term Investments fell 70.32% to $10.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $10.0 million through Sep 2024, down 70.32% year-over-year, with the annual reading at $7.5 million for FY2023, N/A changed from the prior year.
  • Long-Term Investments came in at $10.0 million for Q3 2024, down from $26.7 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $33.8 million in Q3 2023 to a low of $7.5 million in Q4 2023.